Last updated: 13 June 2024 at 4:42pm EST

John Stuelpnagel Net Worth




The estimated Net Worth of John R Stuelpnagel is at least $53.2 Million dollars as of 5 June 2023. Mr. Stuelpnagel owns over 10,000 units of 10x Genomics stock worth over $7,375,566 and over the last 21 years he sold TXG stock worth over $45,794,083. In addition, he makes $31,957 as Independent Chairman of the Board at 10x Genomics.

Mr. Stuelpnagel TXG stock SEC Form 4 insiders trading

John has made over 92 trades of the 10x Genomics stock since 2004, according to the Form 4 filled with the SEC. Most recently he sold 10,000 units of TXG stock worth $548,900 on 5 June 2023.

The largest trade he's ever made was selling 30,000 units of 10x Genomics stock on 7 June 2006 worth over $805,200. On average, John trades about 6,854 units every 67 days since 2004. As of 5 June 2023 he still owns at least 333,736 units of 10x Genomics stock.

You can see the complete history of Mr. Stuelpnagel stock trades at the bottom of the page.





John Stuelpnagel biography

John R. Stuelpnagel serves as Independent Chairman of the Board of the Company. He has been Chairman of our board of directors since August 2013. In addition, Dr. Stuelpnagel co-founded and was Executive Chairman of Ariosa Diagnostics from October 2009 to January 2015 when that company was sold to Roche. He was also the Chairman of Sequenta from November 2010 to January 2015 when that company was merged with Adaptive Biotechnologies where he continued as a member of their board of directors from January 2015 to November 2017. Dr. Stuelpnagel has served as the Chairman of Fabric Genomics since August 2009, the Chairman of Inscripta since April 2017, the Chairman of Element Biosciences since September 2017, and a member of the board of directors for Encoded Therapeutics since May 2017. Previously, Dr. Stuelpnagel co-founded Illumina in 1998 where he worked until March 2009. Prior to Illumina, Dr. Stuelpnagel was an associate at CW Group from 1997 to 1998. Dr. Stuelpnagel received his B.S. in Biochemistry and his Doctorate in Veterinary Medicine from the University of California, Davis and his M.B.A. from the University of California, Los Angeles.

What is the salary of John Stuelpnagel?

As the Independent Chairman of the Board of 10x Genomics, the total compensation of John Stuelpnagel at 10x Genomics is $31,957. There are 12 executives at 10x Genomics getting paid more, with Serge Saxonov having the highest compensation of $2,362,960.



How old is John Stuelpnagel?

John Stuelpnagel is 62, he's been the Independent Chairman of the Board of 10x Genomics since 2013. There are no older and 16 younger executives at 10x Genomics.

What's John Stuelpnagel's mailing address?

John's mailing address filed with the SEC is C/O 10X GENOMICS, INC., 6230 STONERIDGE MALL ROAD, PLEASANTON, CA, 94588.

Insiders trading at 10x Genomics

Over the last 5 years, insiders at 10x Genomics have traded over $629,686,183 worth of 10x Genomics stock and bought 487,816 units worth $19,025,295 . The most active insiders traders include Bryan E Roberts, Capital Management I, Llc F..., and Benjamin J. Hindson. On average, 10x Genomics executives and independent directors trade stock every 8 days with the average trade being worth of $1,002,346. The most recent stock trade was executed by Serge Saxonov on 22 August 2024, trading 6,749 units of TXG stock currently worth $152,055.



What does 10x Genomics do?

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell ATAC for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.



What does 10x Genomics's logo look like?

10x Genomics, Inc. logo

Complete history of Mr. Stuelpnagel stock trades at Illumina Inc and 10x Genomics

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
5 Jun 2023 John R Stuelpnagel
Sale 10,000 $54.89 $548,900
5 Jun 2023
333,736
30 Dec 2021 John R Stuelpnagel
Sale 5,000 $150.92 $754,600
30 Dec 2021
341,616
1 Dec 2021 John R Stuelpnagel
Sale 5,000 $151.16 $755,800
1 Dec 2021
346,616
16 Nov 2021 John R Stuelpnagel
Sale 5,000 $158.83 $794,150
16 Nov 2021
351,616
1 Nov 2021 John R Stuelpnagel
Sale 5,000 $163.51 $817,550
1 Nov 2021
356,616
18 Oct 2021 John R Stuelpnagel
Sale 5,000 $150.67 $753,350
18 Oct 2021
361,616
7 Oct 2021 John R Stuelpnagel
Sale 5,000 $150.18 $750,900
7 Oct 2021
366,616
16 Sep 2021 John R Stuelpnagel
Sale 5,000 $156.33 $781,650
16 Sep 2021
371,616
1 Sep 2021 John R Stuelpnagel
Sale 5,000 $177.48 $887,400
1 Sep 2021
376,616
16 Aug 2021 John R Stuelpnagel
Sale 5,000 $159.56 $797,800
16 Aug 2021
381,616
2 Aug 2021 John R Stuelpnagel
Sale 5,000 $180.42 $902,100
2 Aug 2021
386,616
16 Jul 2021 John R Stuelpnagel
Sale 5,000 $170.31 $851,550
16 Jul 2021
391,616
1 Jul 2021 John R Stuelpnagel
Sale 5,000 $191.64 $958,200
1 Jul 2021
396,616
17 Jun 2021 John R Stuelpnagel
Sale 5,000 $199.38 $996,900
17 Jun 2021
401,616
1 Jun 2021 John R Stuelpnagel
Sale 7,500 $174.49 $1,308,675
1 Jun 2021
405,991
17 May 2021 John R Stuelpnagel
Sale 7,500 $141.57 $1,061,775
17 May 2021
413,491
3 May 2021 John R Stuelpnagel
Sale 7,500 $191.81 $1,438,575
3 May 2021
420,991
16 Apr 2021 John R Stuelpnagel
Sale 7,500 $192.61 $1,444,575
16 Apr 2021
428,491
1 Apr 2021 John R Stuelpnagel
Sale 7,500 $184.53 $1,383,975
1 Apr 2021
435,991
17 Mar 2021 John R Stuelpnagel
Sale 7,500 $169.36 $1,270,200
17 Mar 2021
443,491
1 Mar 2021 John R Stuelpnagel
Sale 7,500 $183.18 $1,373,850
1 Mar 2021
450,991
16 Feb 2021 John R Stuelpnagel
Sale 7,500 $193.00 $1,447,500
16 Feb 2021
458,491
1 Feb 2021 John R Stuelpnagel
Sale 7,500 $176.05 $1,320,375
1 Feb 2021
465,991
19 Jan 2021 John R Stuelpnagel
Sale 7,500 $178.76 $1,340,700
19 Jan 2021
473,491
4 Jan 2021 John R Stuelpnagel
Sale 7,500 $139.86 $1,048,950
4 Jan 2021
480,991
16 Dec 2020 John R Stuelpnagel
Sale 7,500 $148.21 $1,111,575
16 Dec 2020
488,491
1 Dec 2020 John R Stuelpnagel
Sale 7,500 $151.23 $1,134,225
1 Dec 2020
495,991
17 Nov 2020 John R Stuelpnagel
Sale 7,500 $135.98 $1,019,850
17 Nov 2020
503,491
2 Nov 2020 John R Stuelpnagel
Sale 7,500 $136.36 $1,022,700
2 Nov 2020
510,991
16 Oct 2020 John R Stuelpnagel
Sale 7,500 $164.26 $1,231,950
16 Oct 2020
518,491
1 Oct 2020 John R Stuelpnagel
Sale 7,500 $125.60 $942,000
1 Oct 2020
525,991
16 Sep 2020 John R Stuelpnagel
Sale 7,500 $121.63 $912,225
16 Sep 2020
533,491
1 Sep 2020 John R Stuelpnagel
Sale 7,500 $113.92 $854,400
1 Sep 2020
540,991
17 Aug 2020 John R Stuelpnagel
Sale 7,500 $104.67 $785,025
17 Aug 2020
548,491
3 Aug 2020 John R Stuelpnagel
Sale 7,500 $99.34 $745,050
3 Aug 2020
555,991
16 Jul 2020 John R Stuelpnagel
Sale 7,500 $88.86 $666,450
16 Jul 2020
563,491
1 Jul 2020 John R Stuelpnagel
Sale 7,500 $87.58 $656,850
1 Jul 2020
570,991
17 Jun 2020 John R Stuelpnagel
Sale 7,500 $89.14 $668,550
17 Jun 2020
578,491
27 Mar 2008 John R Stuelpnagel
VP Business Development
Option 5,000 $2.77 $13,850
27 Mar 2008
342,836
13 Mar 2008 John R Stuelpnagel
VP Business Development
Option 5,000 $2.77 $13,850
13 Mar 2008
342,836
28 Feb 2008 John R Stuelpnagel
VP Business Development
Option 5,000 $2.77 $13,850
28 Feb 2008
342,836
1 Feb 2008 John R Stuelpnagel
VP Business Development
Option 5,000 $2.77 $13,850
1 Feb 2008
342,619
24 Jan 2008 John R Stuelpnagel
VP Business Development
Option 5,000 $2.77 $13,850
24 Jan 2008
342,396
10 Jan 2008 John R Stuelpnagel
VP Business Development
Option 5,000 $2.77 $13,850
10 Jan 2008
342,396
27 Dec 2007 John R Stuelpnagel
VP Business Development
Option 5,000 $2.77 $13,850
27 Dec 2007
342,396
13 Dec 2007 John R Stuelpnagel
VP Business Development
Option 5,000 $2.77 $13,850
13 Dec 2007
342,396
23 Nov 2007 John R Stuelpnagel
VP Business Development
Option 5,000 $2.77 $13,850
23 Nov 2007
342,396
8 Nov 2007 John R Stuelpnagel
VP Business Development
Option 5,000 $2.77 $13,850
8 Nov 2007
342,396
25 Oct 2007 John R Stuelpnagel
VP Business Development
Option 5,000 $2.77 $13,850
25 Oct 2007
342,396
11 Oct 2007 John R Stuelpnagel
VP Business Development
Option 5,000 $5.99 $29,950
11 Oct 2007
342,396
27 Sep 2007 John R Stuelpnagel
VP Business Development
Option 5,000 $5.99 $29,950
27 Sep 2007
342,396
13 Sep 2007 John R Stuelpnagel
VP Business Development
Option 5,000 $5.99 $29,950
13 Sep 2007
342,396
12 Jul 2007 John R Stuelpnagel
VP Business Development
Sale 15,000 $41.77 $626,550
12 Jul 2007
337,179
12 Jun 2007 John R Stuelpnagel
VP Business Development
Sale 15,000 $36.86 $552,900
12 Jun 2007
352,179
12 Apr 2007 John R Stuelpnagel
VP Business Development
Sale 15,000 $31.00 $465,000
12 Apr 2007
367,179
12 Mar 2007 John R Stuelpnagel
VP Business Development
Sale 15,000 $31.31 $469,650
12 Mar 2007
382,179
12 Jan 2007 John R Stuelpnagel
VP Business Development
Sale 15,000 $39.44 $591,600
12 Jan 2007
396,652
12 Dec 2006 John R Stuelpnagel
VP Business Development
Sale 15,000 $40.44 $606,600
12 Dec 2006
411,652
12 Oct 2006 John R Stuelpnagel
VP Business Development
Sale 15,000 $34.26 $513,900
12 Oct 2006
426,652
12 Sep 2006 John R Stuelpnagel
VP Business Development
Sale 15,000 $33.15 $497,250
12 Sep 2006
439,948
29 Jun 2006 John R Stuelpnagel
VP Business Development
Sale 5,313 $28.63 $152,111
29 Jun 2006
454,948
7 Jun 2006 John R Stuelpnagel
VP Business Development
Sale 30,000 $26.84 $805,200
7 Jun 2006
460,261
29 Mar 2006 John R Stuelpnagel
VP Business Development
Sale 5,313 $27.64 $146,851
29 Mar 2006
490,261
7 Mar 2006 John R Stuelpnagel
VP Business Development
Sale 30,000 $25.07 $752,100
7 Mar 2006
495,574
29 Dec 2005 John R Stuelpnagel
VP Business Development
Sale 5,313 $14.50 $77,039
29 Dec 2005
523,962
2 Dec 2005 John R Stuelpnagel
VP Business Development
Sale 30,000 $15.64 $469,200
2 Dec 2005
529,275
4 Oct 2005 John R Stuelpnagel
VP Business Development
Sale 5,313 $13.24 $70,344
4 Oct 2005
559,275
2 Sep 2005 John R Stuelpnagel
VP Business Development
Sale 30,000 $12.36 $370,800
2 Sep 2005
564,588
11 May 2005 John R Stuelpnagel
VP Business Development
Sale 6,600 $10.18 $67,188
11 May 2005
590,868
9 May 2005 John R Stuelpnagel
VP Business Development
Sale 20,000 $10.19 $203,800
9 May 2005
597,468
22 Apr 2005 John R Stuelpnagel
VP Business Development
Sale 6,683 $9.19 $61,417
22 Apr 2005
617,468
20 Apr 2005 John R Stuelpnagel
VP Business Development
Sale 10,000 $9.00 $90,000
20 Apr 2005
624,151
11 Apr 2005 John R Stuelpnagel
VP Business Development
Sale 5,017 $9.00 $45,153
11 Apr 2005
634,151
18 Jan 2005 John R Stuelpnagel
VP Business Development
Sale 2,747 $9.00 $24,723
18 Jan 2005
635,683
27 Dec 2004 John R Stuelpnagel
VP Business Development
Sale 10,533 $9.31 $98,062
27 Dec 2004
638,430
23 Dec 2004 John R Stuelpnagel
VP Business Development
Sale 5,000 $9.00 $45,000
23 Dec 2004
648,963
16 Dec 2004 John R Stuelpnagel
VP Business Development
Sale 2,500 $8.01 $20,025
16 Dec 2004
653,963
15 Dec 2004 John R Stuelpnagel
VP Business Development
Sale 5,000 $8.00 $40,000
15 Dec 2004
656,463
14 Dec 2004 John R Stuelpnagel
VP Business Development
Sale 5,000 $8.00 $40,000
14 Dec 2004
661,463
13 Dec 2004 John R Stuelpnagel
VP Business Development
Sale 2,500 $8.00 $20,000
13 Dec 2004
666,463
2 Dec 2004 John R Stuelpnagel
VP Business Development
Sale 5,000 $8.00 $40,000
2 Dec 2004
668,963
1 Dec 2004 John R Stuelpnagel
VP Business Development
Sale 5,000 $8.00 $40,000
1 Dec 2004
673,963
24 Nov 2004 John R Stuelpnagel
VP Business Development
Sale 5,000 $8.00 $40,000
24 Nov 2004
678,963
18 Oct 2004 John R Stuelpnagel
VP Business Development
Sale 2,747 $7.00 $19,229
18 Oct 2004
683,963
21 Sep 2004 John R Stuelpnagel
VP Business Development
Sale 3,274 $7.00 $22,918
21 Sep 2004
686,710
17 Sep 2004 John R Stuelpnagel
VP Business Development
Sale 100 $7.20 $720
17 Sep 2004
689,984
23 Jun 2004 John R Stuelpnagel
VP Business Development
Sale 3,800 $7.00 $26,600
23 Jun 2004
690,084
9 Jun 2004 John R Stuelpnagel
VP Business Development
Sale 5,000 $7.05 $35,250
9 Jun 2004
693,884
8 Jun 2004 John R Stuelpnagel
VP Business Development
Sale 5,000 $7.10 $35,500
8 Jun 2004
698,884
7 Jun 2004 John R Stuelpnagel
VP Business Development
Sale 5,000 $7.00 $35,000
7 Jun 2004
703,884
4 Jun 2004 John R Stuelpnagel
VP Business Development
Sale 79 $7.00 $553
4 Jun 2004
708,884
2 Jun 2004 John R Stuelpnagel
VP Business Development
Sale 5,000 $7.00 $35,000
2 Jun 2004
708,963


10x Genomics executives and stock owners

10x Genomics executives and other stock owners filed with the SEC include: